Summary: In a short video, Unpacked interviews Keren Tzarfaty, Ph.D., M.F.T., Director of Israeli Projects and Collaborations at MAPS. Tzarfaty explains that MDMA-assisted psychotherapy sessions may allow participants to “actually touch the trauma, ask questions about it, and really process it on an emotional level, cognitive level, physical level, [and] biological level.”
Originally appearing here.
This week, Unpacked explains why the street drug MDMA, often found in Ecstasy or Molly, might just hold the key to helping sufferers of post-traumatic stress disorder (PTSD). It might seem a crazy – or even controversial – approach to take, but a possibly revolutionary MDMA treatment, pioneered by research led by the California-based nonprofit MAPS (Multidisciplinary Association for Psychedelic Studies) – which has research facilities in the US, Canada, and Israel – is showing very promising results. While the research is ongoing, medical researchers believe this approach might just be a way to end suffering for a population that has had to deal with life-altering trauma.